PEN
Penumbra Inc
NYSE · Healthcare · Medical - Devices · US
$322.45
+0.76%Next report
Analyst consensus
- Next report date
- Feb 24, 2027
- EPS estimate
- $1.44
- Revenue estimate
- $428.1M
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $1.07
- EPS estimate
- $1.20
- Revenue actual
- $410.1M
- Revenue estimate
- $401.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -13.3%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $1.20 | $1.07 | Miss -10.83% | $410.1M |
| Jul 30, 2026 | $1.16 | $0.88 | Miss -24.14% | $390.0M |
| May 6, 2026 | $1.06 | $0.82 | Miss -22.64% | $374.8M |
| Nov 5, 2025 | $0.93 | $0.97 | Beat 4.41% | $354.7M |
| Jul 29, 2025 | $0.81 | $0.86 | Beat 6.17% | $339.5M |
| Apr 23, 2025 | $0.66 | $0.83 | Beat 25.76% | $324.1M |
| Feb 18, 2025 | $0.88 | $0.97 | Beat 10.23% | $315.5M |
| Feb 22, 2024 | $0.71 | $0.76 | Beat 7.04% | $284.7M |
| Nov 2, 2023 | $0.46 | $0.67 | Beat 45.65% | $270.9M |
| Aug 1, 2023 | $0.28 | $0.43 | Beat 53.57% | $261.5M |
| May 2, 2023 | $0.11 | $0.23 | Beat 109.09% | $241.4M |
| Feb 23, 2023 | $0.14 | $0.16 | Beat 14.29% | $221.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 24, 2027